Anorexia (in the cPNI context) refers to the inflammation-induced loss of appetite that forms a core component of the sickness behaviour response. It is mediated by pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) acting on hypothalamic feeding circuits to suppress hunger signals and redirect metabolic resources toward immune defense and tissue repair during acute infection or inflammation.
Imagine your body as a city during wartime. Normally, the food distribution center (arcuate nucleus) sends regular supply trucks (NPY/AgRP neurons) throughout the city encouraging everyone to eat, build, and expand. But when enemy forces invade (infection/inflammation), the city's alarm system (cytokines) broadcasts a red alert. The military command (hypothalamus) immediately shuts down the civilian food distribution center and redirects all resources—fuel, materials, workers—to the defense factories and repair crews (immune cells, tissue healing). The supply trucks stop running. Citizens aren't hungry because the city has switched to "survival mode"—all energy goes to fighting the invasion, not to building new infrastructure or expanding the population. This works brilliantly for a short siege (acute infection). But if the alarm never turns off (chronic inflammation), the city begins to starve itself, burning through its own buildings for fuel (muscle wasting, cachexia), even as some neighborhoods paradoxically hoard supplies and become obese (hypothalamic inflammation causing opposite phenotypes depending on which pathway breaks first).
The inflammatory anorexia cascade begins when peripheral immune activation generates pro-inflammatory cytokines that signal to the brain via multiple routes:
Peripheral-to-Central Signaling:
Hypothalamic Circuit Suppression:
IL-1β + TNF-α → act on arcuate nucleus of hypothalamus:
-
Orexigenic pathway suppression:
- IL-1β → inhibits NPY/AgRP neurons (hunger-promoting)
- TNF-α → induces leptin resistance via SOCS3 upregulation
- Suppressed NPY/AgRP → reduced hunger signaling to lateral hypothalamus
-
Anorexigenic pathway activation:
- IL-1β → directly activates melanocortin receptors (MC3R/MC4R)
- Activates POMC/CART neurons (satiety-promoting)
- POMC cleaved to α-MSH → binds MC4R → appetite suppression
-
Additional mechanisms:
- TNF-α → activates NF-kB → increases POMC transcription
- IL-6 → activates JAK-STAT pathway → alters leptin sensitivity
- All three cytokines → increase hypothalamic PGE2 → suppresses feeding behavior
graph TD
A[Peripheral Infection/Inflammation] --> B["IL-1β, IL-6, TNF-α"]
B --> C[Cross BBB via Circumventricular Organs]
B --> D[Activate Vagal Afferents]
B --> E["Activate Brain Endothelium → PGE2"]
C --> F[Hypothalamic Cytokine Signaling]
D --> F
E --> F
F --> G[Arcuate Nucleus]
G --> H[Suppress NPY/AgRP neurons]
G --> I[Activate POMC/CART neurons]
H --> J[Reduced Hunger Signals]
I --> K["IL-1β → MC4R activation"]
I --> L[Increased Satiety Signals]
F --> M["TNF-α → Leptin Resistance via SOCS3"]
M --> N[Disrupted Energy Balance]
J --> O[ANOREXIA]
K --> O
L --> O
N --> O
O --> P{Duration}
P -->|Acute| Q["Adaptive: Energy Conservation for Immune Function"]
P -->|Chronic| R["Maladaptive: Cachexia or Paradoxical Obesity"]
Chronic Hypothalamic Inflammation — Dual Phenotypes:
When hypothalamic neuroinflammation becomes chronic:
- Anorexia pathway: Persistent IL-1β/TNF-α → sustained POMC activation → chronic appetite suppression → cachexia
- Obesity pathway: Chronic inflammation → POMC/leptin receptor resistance → loss of satiety signals → hyperphagia despite inflammation → obesity
- The phenotype depends on which receptor system develops cytokine resistance first
Exam Relevance: Inflammation-induced anorexia is a perfect example of antagonistic pleiotropy—a mechanism that is adaptive in acute situations (conserve energy during infection) becomes maladaptive when chronically activated (malnutrition, muscle wasting). This connects directly to the selfish immune system concept: the immune system prioritizes its own needs over the whole organism, triggering anorexia to redirect metabolic resources even when it causes long-term harm.
Clinical Populations:
- Cancer patients: Tumor-associated chronic inflammation → IL-6/TNF-α elevation → persistent anorexia → cachexia (seen in 50-80% of advanced cancer)
- Autoimmune diseases: RA, lupus, IBD patients often present with unexplained weight loss and appetite suppression despite adequate caloric availability
- Depression: Shared inflammatory pathway (IL-1β, TNF-α) explains appetite loss in major depressive disorder; CRP >3 mg/L correlates with anorexia severity
- Long COVID: Persistent anorexia months post-infection suggests ongoing hypothalamic neuroinflammation and microglial activation
- Chronic infections: TB, HIV, hepatitis C—all show IL-1β-driven appetite suppression
Biomarker Thresholds:
- IL-6 >10 pg/mL → significant appetite suppression
- TNF-α >8 pg/mL → leptin resistance likely
- CRP >5 mg/L → inflammatory anorexia probable
- In experimental models: repeated LPS challenge → 60-80% reduction in milk intake within 24h
Intervention Implications:
- Address root inflammation, not just calories: Force-feeding without treating underlying inflammation paradoxically increases metabolic stress
- Anti-inflammatory nutrition: Omega-3, curcumin, resolvins to reduce IL-1β/TNF-α
- Restore hypothalamic sensitivity: berberine, time-restricted eating, cold exposure may reduce hypothalamic inflammation
- Distinguish phenotypes: Chronic hypothalamic inflammation can present as anorexia OR obesity—same mechanism, different downstream resistance patterns
- Micronutrient support: zinc, vitamin D, selenium to modulate cytokine production
Metamodel Connections:
- Selfish immune system: Appetite suppression prioritizes immune needs over whole-organism energy balance
- Evolutionary mismatch: Acute anorexia evolved for short-term infections (days); modern chronic inflammation (years) turns adaptive into maladaptive
- Chronic low-grade inflammation: The mechanistic link between obesity, depression, autoimmunity, and cancer-related cachexia
- Part of evolutionarily conserved sickness behaviour alongside fatigue, social withdrawal, fever
- Mediated by IL-1β (strongest effect), TNF-α (leptin resistance), IL-6 (amplifier)
- Suppresses NPY/AgRP orexigenic neurons in arcuate nucleus
- Activates POMC/CART anorexigenic pathways via melanocortin receptor stimulation
- IL-1β directly binds and activates MC3R/MC4R receptors independent of leptin
- TNF-α induces leptin resistance via SOCS3 upregulation, disrupting satiety feedback
- Experimental LPS challenge reduces food intake by 60-80% within 24h in rodent models
- Adaptive in acute infection: conserves 20-30% of basal metabolic rate for immune activation
- Maladaptive in chronic inflammation: contributes to cachexia (muscle wasting + inflammation + anorexia triad)
- Chronic hypothalamic neuroinflammation produces two opposing phenotypes: persistent anorexia OR obesity, depending on which receptor pathway becomes resistant
- Shared mechanism with depression: IL-1β-mediated appetite suppression explains melancholic depression's anorexia component
- Long COVID anorexia may indicate persistent microglial activation and ongoing CNS inflammation months post-infection
- Cannot be reversed by simply increasing caloric intake—requires addressing upstream inflammation
- Cachexia (defined as >5% weight loss + inflammation + anorexia) predicts poor outcomes in cancer, COPD, heart failure
- IL-1β — primary cytokine driving appetite suppression via melanocortin receptor activation
- TNF-α — induces leptin resistance through SOCS3, disrupts energy balance signaling
- IL-6 — amplifies hypothalamic inflammatory cascade, contributes to chronic anorexia
- hypothalamus — central integration site where cytokines suppress feeding circuits
- arcuate nucleus — contains NPY/AgRP (orexigenic) and POMC/CART (anorexigenic) neurons targeted by inflammation
- NPY — orexigenic neuropeptide suppressed by IL-1β during inflammation
- AgRP — agouti-related peptide, hunger-promoting signal inhibited by cytokines
- POMC — pro-opiomelanocortin, cleaved to α-MSH which activates anorexigenic melanocortin receptors
- CART protein — cocaine-amphetamine-regulated transcript, co-released with POMC to suppress appetite
- melanocortin receptors — MC3R/MC4R directly activated by IL-1β, mediate satiety signals
- leptin resistance — induced by TNF-α via SOCS3, blocks leptin's satiety signal despite adequate adipose stores
- sickness behaviour — anorexia is cardinal feature alongside fatigue, hyperalgesia, social withdrawal
- hypothalamic neuroinflammation — chronic state producing either anorexia (POMC pathway intact) or obesity (POMC resistance)
- chronic low-grade inflammation — links anorexia, cachexia, obesity, depression through shared cytokine pathways
- cachexia — severe syndrome: >5% weight loss + muscle wasting + anorexia + inflammation
- depression — shares IL-1β/TNF-α-mediated appetite suppression mechanism with inflammatory anorexia
- Long COVID — persistent anorexia suggests ongoing hypothalamic and microglial inflammation
- obesity — paradoxical outcome when chronic hypothalamic inflammation causes melanocortin/leptin receptor resistance
- microglia — CNS-resident immune cells that amplify peripheral cytokine signals locally in hypothalamus
- circumventricular organs — brain regions lacking blood-brain barrier, allow peripheral cytokines direct CNS access
- prostaglandin E2 — induced by peripheral cytokines in brain endothelium, crosses BBB to suppress appetite
- nucleus tractus solitarius — receives vagal cytokine signals, relays to hypothalamus
- vagus nerve — carries peripheral inflammatory signals centrally via afferent fibers
- SOCS3 — suppressor of cytokine signaling protein upregulated by TNF-α, blocks leptin receptor
- LPS — experimental endotoxin trigger demonstrating 60-80% appetite reduction in inflammation models
- cancer — tumor-associated inflammation drives cachexia through IL-6/TNF-α-mediated anorexia
- rheumatoid arthritis — chronic TNF-α/IL-1β elevation contributes to unexplained weight loss
- inflammatory bowel disease — IL-1β from gut inflammation signals to hypothalamus, causing appetite suppression
- tuberculosis — chronic infection model of inflammation-induced wasting and anorexia
- HIV — persistent immune activation causes cachexia syndrome via cytokine-mediated anorexia
- Module 1 — Sickness behaviour and inflammatory cascades introduced
- Module 3 — Neuroendocrine integration, hypothalamic inflammation, dual obesity/anorexia phenotypes
- Module 8 — Clinical diagnosis of inflammation-driven appetite disorders, shame-based eating disorders vs inflammatory anorexia